CGEM
NASDAQ · Biotechnology
Cullinan Therapeutics Inc
$21.36
+0.01 (+0.05%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+0.4% upside
Low Target
$16.94
Average Target
$21.45
High Target
$32.37
Current Price
$21.36
Current
$21.36
$21.36
Target
$21.45
$21.45
$16.94
$21.45 avg
$32.37
Scenario Analysis
Bear Case
$16.94
-20.7%
Low target
Base Case
$21.45
+0.4%
Avg target
Bull Case
$32.37
+51.5%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$23.19
-7.9% from high
52-Week Low
$5.68
+276.1% from low
Target vs 52W High
$21.45
-7.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |